SQZ Biotech Exec Agarwal Surfaces as Epizyme Chief Medical Officer

Shefali Agarwal has joined Cambridge, MA-based Epizyme (NASDAQ: [[ticker:EPZM]]) as chief medical officer. Before coming to Epizyme, Agarwal most recently worked at SQZ Biotech, where she was chief medical officer. She has also held leadership roles at Curis and Tesaro (NASDAQ: [[ticker:TSRO]]). Epizyme develops therapies based on epigenetics—turning certain genes on or off without altering the underlying genetic sequence. The company’s lead drug candidate, tazemetostat, is in Phase 1 and 2 studies testing it as a treatment for several different types of cancer.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.